Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice. Alzforum, 09 Apr 2021 Ali T, Hannaoui S, Nemani S, Tahir W, Zemlyankina I, Cherry P, Shim SY, Sim V, Schaetzl HM, Gilch S.
